Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cell cycle progression and induction of apoptosis

By Orlandi L.   Colella G.   Bearzatto A.   Abolafio G.   Manzotti C.   Daidone M.G.   Zaffaroni N.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 649-659

Elsevier

Access to resources Recommend Favorite

Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatin

By Sharp S.Y.   O'Neill C.F.   Rogers P.   Boxall F.E.   Kelland L.R.  

European Journal of Cancer, Vol. 38, Iss. 17, 2002-11 ,pp. : 2309-2315

Elsevier

Access to resources Recommend Favorite

Schedule-dependent synergism and antagonism between pemetrexed and paclitaxel in human carcinoma cell lines in vitro

By Kano Yasuhiko   Akutsu Miyuki   Tsunoda Saburo   Izumi Tohru   Mori Kiyoshi   Fujii Hirofumi   Yazawa Yasuo   Mano Hiroyuki   Furukawa Yusuke  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 6, 2004-12 ,pp. : 505-513

Springer Publishing Company

Access to resources Recommend Favorite

Schedule-dependent Antagonism of Paclitaxel and Cisplatin in Human Gastric and Ovarian Carcinoma Cell Lines In Vitro

By Vanhoefer U.   Harstrick A.   Wilke H.   Schleucher N.   Walles H.   Schroder J.   Seeber S.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 92-97

Elsevier

Access to resources Recommend Favorite

Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines

By Holford J.   Beale P.J.   Boxall F.E.   Sharp S.Y.   Kelland L.R.  

European Journal of Cancer, Vol. 36, Iss. 15, 2000-10 ,pp. : 1984-1990

Elsevier

Access to resources Recommend Favorite